newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment

Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael WellerAccess the segment here HOUSTON, TX / ACCESSWIRE / November 4, 2024 / CNS Pharmaceuticals, Inc.